Meeting Banner
Abstract #2189

Longitudinal quantitative MRI Provides Quality Assurance Measures in Patients with Ischemic Stroke Treated with Autologous Bone Marrow Derived Mononuclear Cells.

Muhammad E Haque 1 , Khader M Hasan 2 , Benjamin A Schatz 3 , Sarah M Lund 3 , Farhaan S Vahidy 4 , and Sean I Savitz 4

1 Neurology, Unversity of Texas Health Science Center at Houston, Houston, TX, United States, 2 Diagnostic and Interventional Imaging, Unversity of Texas Health Science Center at Houston, Houston, TX, United States, 3 Unversity of Texas Health Science Center at Houston, TX, United States, 4 Neurology, Unversity of Texas Health Science Center at Houston, TX, United States

Post stroke cell therapy may offer a promising regenerative therapy. There is a need to establish reliable neuroimaging markers to assure safety and help advance neubiological models. In this study we sought to present some quality assurance measures by testing the integrity of white matter fibers in the anterior and posterior corpus callosum regions post MCA stroke.

This abstract and the presentation materials are available to members only; a login is required.

Join Here